Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris 15:09:11 09/09/2024 BST 5-day change 1st Jan Change
53.30 EUR +1.06% Intraday chart for Eurofins Scientific SE +4.14% -9.63%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Eurofins Scientific: new share buyback program CF
Eurofins Scientific Launches New Share Buyback Program MT
Eurofins Scientific SE authorizes a Buyback Plan. CI
Eurofins Scientific SE announces an Equity Buyback for 2% of its issued share capital. CI
CAC40: timid rise in limited volumes CF
Eurofins: mpox virus tests now available CF
EUROFINS SCIENTIFIC : EPS upgrade (2024: +8.9%, 2025: +8.0%) Alphavalue
CAC40: limited movement for the weekend CF
Which way to go? Our Logo
Q2 2024: Strong TIC, weak staffers, fairly priced outsourcing and solid Securitas Alphavalue
Eurofins: UK approves takeover of Cellmark CF
UK Competition Watchdog Clears Eurofins Scientific's Purchase of Cellmark MT
EUROFINS SCIENTIFIC : H1 beat + intact guidance Alphavalue
Global markets live: Tesla, Alphabet, Visa, Apple, Ford, IBM... Our Logo
Transcript : Eurofins Scientific SE, H1 2024 Earnings Call, Jul 24, 2024
Eurofins: 46% growth in half-year net profit CF
Eurofins: Adjusted profit rises in H1 RE
Eurofins Scientific SE Reports Earnings Results for the Half Year Ended June 30, 2024 CI
Eurofins Scientific SE Provides Earnings Guidance for the Fiscal Year 2024 CI
Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on October 20, 2023. CI
Eurofins: investigation launched into UK takeover of Cellmark CF
UK Competition Watchdog Begins Probe of Eurofins' Purchase of Technical Testing, Analysis Business MT
Eurofins: dispute with SGS over termination of contract CF
Eurofins Scientific SE cancelled the acquisition of SGS crop science operations in 14 countries from SGS SA. CI
Eurofins: further clarifications for the market CF
Chart Eurofins Scientific SE
More charts
Logo Eurofins Scientific SE
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Employees
61,798
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
52.74EUR
Average target price
59.91EUR
Spread / Average Target
+13.59%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERF Stock
  4. News Eurofins Scientific SE
  5. UK Competition Watchdog Clears Eurofins Scientific's Purchase of Cellmark
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW